High-Affinity Target BindingScalable Diagnostic & Biosensor Solutions
We specialize in delivering end-to-end biotin aptamer services that empower researchers, diagnostic developers, and biosensor innovators to achieve precise and reliable results. By combining advanced SELEX technology, proprietary oligonucleotide chemistry, and proven biotin-streptavidin conjugation strategies, we create aptamers with superior affinity, stability, and versatility. Whether you need aptamers for small molecules, proteins, peptides, or complex targets, our custom development pipeline ensures rapid turnaround, reproducible performance, and seamless integration into your workflows-helping you accelerate innovation while reducing costs.
Aptamers selected and optimized for your target ensure strong affinity and minimal cross-reactivity.
Biotin-labeled aptamers leverage the biotin-streptavidin system for stable, efficient surface attachment and signal enhancement.
Aptamers can often be generated faster, at lower cost, and with greater stability than conventional antibodies.
Aptamer-biotin conjugates improve detection limits in ELAA, LFA, biosensor chips, and other platforms.
Synthetic aptamers are chemically defined and easily reproduced, ensuring consistent performance from R&D to production.
We begin with a detailed consultation to understand your target, application, and performance requirements.
Our scientific team evaluates project viability, designs a selection strategy, and outlines timelines and deliverables.
Iterative rounds of SELEX combined with advanced sequencing and bioinformatics to identify high-affinity candidates.
Custom chemical labeling and structural optimization to ensure compatibility with your intended assay or platform.
Comprehensive characterization including binding affinity (Kd), specificity testing, and performance data in relevant conditions.
Production of biotin aptamers at research or GMP-grade scale, with full documentation and quality assurance.
Each biotin aptamer is selected through a rigorous SELEX process with counter-selection, ensuring strong target recognition and minimal cross-reactivity-outperforming traditional antibodies in precision.
Chemically synthesized aptamers with biotin modifications remain stable under a wide range of temperatures and buffers, enabling reliable performance in both laboratory and point-of-care environments.
Aptamers can be reproduced chemically at scale without batch-to-batch variability, offering a more affordable and consistent alternative to conventional antibody production.
Our optimized workflows shorten development time, allowing you to receive functional, validated aptamers in weeks rather than months, accelerating your project timelines.
With biotin labeling, aptamers easily integrate into ELAA, lateral flow assays, biosensors, and microfluidic devices-reducing development complexity and boosting assay performance.
From small pilot projects to large-volume GMP manufacturing, our services are designed to grow with your needs, supporting research, diagnostics, and commercialization alike.
Yes, in many cases. Aptamers offer similar or higher affinity, improved stability, and lower batch variability, making them strong alternatives to antibodies in diagnostics and biosensors.
Yes, we support projects from early research to GMP-compliant manufacturing, ensuring smooth scalability from bench to market.
All aptamers undergo binding affinity (Kd) testing, specificity profiling, and stability assessments, with full reports provided to the client.
Absolutely. We offer a wide range of chemical modifications including fluorophores, spacers, and backbone stabilization to fit your application.
We can develop aptamers against small molecules, proteins, peptides, cells, or even whole pathogens, depending on your project goals.
Unlock the potential of custom biotin aptamer solutions to enhance your diagnostics, biosensors, or research applications. Our expert team delivers high-affinity, validated, and scalable aptamers tailored to your exact needs. Contact us today for a free consultation or quote, and take the next step toward faster, more reliable, and cost-effective results.